Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

J Immunol. 1995 Aug 1;155(3):1151-64. Unique Identifier : AIDSLINE MED/95363080
Sakaguchi S; Sakaguchi N; Asano M; Itoh M; Toda M; Precursory Research for Embryonic Science and Technology; (PRESTO), Research and Development Corporation of Japan (JRDC),; Tsukuba Life Science Center.


Abstract: Approximately 10% of peripheral CD4+ cells and less than 1% of CD8+ cells in normal unimmunized adult mice express the IL-2 receptor alpha-chain (CD25) molecules. When CD4+ cell suspensions prepared from BALB/c nu/+ mice lymph nodes and spleens were depleted of CD25+ cells by specific mAb and C, and then inoculated into BALB/c athymic nude (nu/nu) mice, all recipients spontaneously developed histologically and serologically evident autoimmune diseases (such as thyroiditis, gastritis, insulitis, sialoadenitis, adrenalitis, oophoritis, glomerulonephritis, and polyarthritis); some mice also developed graft-vs-host-like wasting disease. Reconstitution of CD4+CD25+ cells within a limited period after transfer of CD4+CD25- cells prevented these autoimmune developments in a dose-dependent fashion, whereas the reconstitution several days later, or inoculation of an equivalent dose of CD8+ cells, was far less efficient for the prevention. When nu/nu mice were transplanted with allogeneic skins or immunized with xenogeneic proteins at the time of CD25- cell inoculation, they showed significantly heightened immune responses to the skins or proteins, and reconstitution of CD4+CD25+ cells normalized the responses. Taken together, these results indicate that CD4+CD25+ cells contribute to maintaining self-tolerance by down-regulating immune response to self and non-self Ags in an Ag-nonspecific manner, presumably at the T cell activation stage; elimination/reduction of CD4+CD25+ cells relieves this general suppression, thereby not only enhancing immune responses to non-self Ags, but also eliciting autoimmune responses to certain self-Ags. Abnormality of this T cell-mediated mechanism of peripheral tolerance can be a possible cause of various autoimmune diseases.
Keywords: Animal Autoimmune Diseases/ETIOLOGY/*IMMUNOLOGY/PREVENTION & CONTROL CD4-Positive T-Lymphocytes/*IMMUNOLOGY/METABOLISM/TRANSPLANTATION CD8-Positive T-Lymphocytes/IMMUNOLOGY Female Graft vs Host Disease/ETIOLOGY/*IMMUNOLOGY/PREVENTION & CONTROL Immunotherapy, Adoptive/ADVERSE EFFECTS Interleukin-2/*PHYSIOLOGY Isoantigens/IMMUNOLOGY Lymphocyte Depletion Mice Mice, Inbred BALB C Mice, Nude Receptors, Interleukin-2/BIOSYNTHESIS/*PHYSIOLOGY Self Tolerance/*IMMUNOLOGY Skin Transplantation/IMMUNOLOGY Support, Non-U.S. Gov't T-Lymphocyte Subsets/*IMMUNOLOGY/METABOLISM/TRANSPLANTATION JOURNAL ARTICLE

KWDanimalautoimmunediseases/etiology/KWDimmunology/prevention&controlcd4-positivet-lymphocytes/KWDimmunology/metabolism/transplantationcd8-positivet-lymphocytes/immunologyfemalegraftvshostdisease/etiology/KWDimmunology/prevention&controlimmunotherapy,adoptive/adverseeffectsinterleukin-2/KWDphysiologyisoantigens/immunologylymphocytedepletionmicemice,inbredbalbcmice,nudereceptors,interleukin-2/biosynthesis/KWDphysiologyselftolerance/KWDimmunologyskintransplantation/immunologysupport,non-uKWDsKWDgov'tt-lymphocytesubsets/KWDimmunology/metabolism/transplantationjournalarticle
951130
M95B0413


Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .